To overcome this problem, Pharma introduced a diabolically cunning strategy to euthanize three birds with one stone. The companies withdrew their flagging Hib and hepatitis B vaccines and reissued a new concoction that combined those immunizations with the DTP, which, despite its popularity, had become another sandbag on Big Pharma’s profit ambitions.
